About 2,640,000 results
Open links in new tab
  1. Novo Nordisk A/S: Lars Fruergaard Jørgensen to step down as

    May 16, 2025 · As per mutual agreement with the Novo Nordisk Board, Lars Fruergaard Jørgensen will step down from his role as CEO of Novo Nordisk.

  2. CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down

    Novo Nordisk’s share price is down 54% from its peak in June 2024. Its U.S.-listed shares fell another 3% in morning trading Friday. The company, headquartered in Bagsvaerd, Denmark, praised a “significant growth journey and transformation” led …

  3. Novo's longtime CEO Lars Fruergaard Jørgensen to step down

    May 16, 2025 · It’s the end of an era at Novo Nordisk as longtime CEO Lars Fruergaard Jørgensen—who recently shepherded the company through its GLP-1 growth boom—heads for the exit.

  4. CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down

    May 16, 2025 · Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by “mutual agreement” with the company's board of directors ...

  5. Novo Nordisk ousts CEO as Wegovy maker faces growing …

    May 16, 2025 · Novo Nordisk CEO Lars Jorgensen testifies before a Senate Health, Education, Labor, and Pensions Committee hearing on U.S. prices for the weight loss drugs Ozempic and …

  6. Wegovy maker Novo Nordisk CEO to step down - Axios

    May 16, 2025 · Novo Nordisk CEO Lars Fruergaard Jørgensen is stepping down as the Danish drug giant faces increased competition for its weight-loss drugs and declining share price.

  7. Novo CEO to depart as obesity drugmaker’s challenges rise

    May 16, 2025 · Novo Nordisk CEO Lars Fruergaard Jørgensen, who led the Danish drugmaker to new heights through its development of powerful medicines for diabetes and obesity, will step down from his position, the company said Friday.

  8. Novo Nordisk CEO, who led company into weight-loss drugs, to step down

    Novo Nordisk, the maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by "mutual agreement" with the company's board of directors, citing "recent market...

  9. Novo Nordisk CEO Lars Fruergaard Jørgensen to Step Down

    May 16, 2025 · Novo Nordisk has announced that Lars Fruergaard Jørgensen will step down as CEO, following a mutual agreement with the company’s board of directors. According to the company, Jørgensen is expected to remain in the role while a search for his successor is underway, aiming for a smooth transition.

  10. Novo Nordisk CEO steps down amid competition for weight loss …

    May 16, 2025 · Danish pharmaceutical giant Novo Nordisk is saying goodbye to its chief executive amid growing competition for its blockbuster weight loss drugs Wegovy and Ozempic.

  11. Some results have been removed